Open AccessA Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Tolerability, and Safety of Celecoxib Oral Solution (ELYXYB) in Acute Treatment of Episodic Migraine with or without Aura
Author(s) -
Richard B. Lipton,
Sagar Munjal,
Stewart J. Tepper,
Charles Iaconangelo,
Daniel Serrano
Publication year - 2021
Publication title -
journal of pain research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.888
H-Index - 49
ISSN - 1178-7090
DOI - 10.2147/jpr.s322292
Subject(s) - medicine , tolerability , celecoxib , placebo , migraine , phonophobia , nausea , anesthesia , photophobia , aura , placebo controlled study , adverse effect , surgery , double blind , alternative medicine , pathology
Safe, effective, oral therapies are needed for acute treatment of migraine. This clinical trial assessed the efficacy, tolerability, and safety of celecoxib oral solution (ELYXYB) in a single migraine attack associated with moderate-to-severe pain.